Suppr超能文献

来自正常供体的细胞毒性淋巴细胞。人类非T淋巴细胞的一种功能标志物。

Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.

作者信息

Pross H F, Jondal M

出版信息

Clin Exp Immunol. 1975 Aug;21(2):226-35.

Abstract

A phenomenon we have termed spontaneous lymphocyte-mediated cytotoxicity (SLMC) by non-thymus-derived lymphocytes from normal donors has been described. The phenomenon can be demonstrated using human and xenogeneic (mouse) cell lines as the target cell in a microplate 51Cr release assay which is simple and reproducible. In this paper, SLMC against xenogeneic targets has been evaluated as a potential marker of lumphocytotoxic function with respect to: (a) the nature of the target cell; (b) the variability of the cytotoxic function of lymphocytes from different donors, and from the same donor tested on different days; (c) the nature of the effector cell. Using buoyant density centrifugation of iron plus magnetpurified lymphocytes forming rosettes with sheep red blood cells (SRBC) (T-cells) or SRBC-rabbit 19S anti-SRBC-mouse complement (complement receptor lymphocyte), it has been demonstrated that the cytotoxic activity lies in the non-T-lymphocyte fraction, and is probably caused by the complement receptor-bearing lymphocyte. The potential usefulness of this phenomenon as a functional marker of non-T-LYMPHOCYTE CYTOTOXIC Ability, and for the assessment of serological factors ehich may affect this cytotoxicity, has been discussed.

摘要

我们已经描述了一种现象,即来自正常供体的非胸腺衍生淋巴细胞介导的自发淋巴细胞毒性(SLMC)。该现象可以在微孔板51Cr释放试验中,使用人源和异种(小鼠)细胞系作为靶细胞来证明,该试验简单且可重复。在本文中,针对异种靶标的SLMC已被评估为淋巴细胞毒性功能的潜在标志物,涉及以下方面:(a)靶细胞的性质;(b)不同供体以及同一供体在不同日期测试的淋巴细胞毒性功能的变异性;(c)效应细胞的性质。通过对与绵羊红细胞(SRBC)形成花环的铁加磁珠纯化淋巴细胞(T细胞)或SRBC-兔19S抗SRBC-小鼠补体(补体受体淋巴细胞)进行浮力密度离心,已证明细胞毒性活性存在于非T淋巴细胞部分,并且可能由携带补体受体的淋巴细胞引起。本文讨论了这种现象作为非T淋巴细胞细胞毒性能力的功能标志物以及评估可能影响这种细胞毒性的血清学因素的潜在用途。

相似文献

引用本文的文献

1
Five decades of natural killer cell discovery.
J Exp Med. 2024 Aug 5;221(8). doi: 10.1084/jem.20231222. Epub 2024 Jun 6.
2
Therapeutic approaches to enhance natural killer cell cytotoxicity.
Front Immunol. 2024 Mar 11;15:1356666. doi: 10.3389/fimmu.2024.1356666. eCollection 2024.
3
Combination of NK and Other Immune Markers at Early Phase Stratify the Risk of Sepsis Patients: A Retrospective Study.
J Inflamm Res. 2023 Oct 18;16:4725-4732. doi: 10.2147/JIR.S426828. eCollection 2023.
4
Highlights into historical and current immune interventions for cancer.
Int Immunopharmacol. 2023 Apr;117:109882. doi: 10.1016/j.intimp.2023.109882. Epub 2023 Feb 27.
5
Natural killer cells in sepsis: Friends or foes?
Front Immunol. 2023 Jan 26;14:1101918. doi: 10.3389/fimmu.2023.1101918. eCollection 2023.
7
Natural killer cells and acute myeloid leukemia: promises and challenges.
Cancer Immunol Immunother. 2022 Dec;71(12):2849-2867. doi: 10.1007/s00262-022-03217-1. Epub 2022 May 31.
9
The Role of Natural Killer Cells in Autoimmune Diseases.
Front Immunol. 2021 Feb 25;12:622306. doi: 10.3389/fimmu.2021.622306. eCollection 2021.
10
Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells.
Front Immunol. 2020 Oct 29;11:576929. doi: 10.3389/fimmu.2020.576929. eCollection 2020.

本文引用的文献

1
QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS.
Transplantation. 1965 May;3:423-31. doi: 10.1097/00007890-196505000-00011.
3
A transplantable mast-cell neoplasm in the mouse.
J Natl Cancer Inst. 1957 Apr;18(4):587-601.
5
An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.
Transplantation. 1968 Sep;6(6):761-4. doi: 10.1097/00007890-196809000-00002.
6
Multiple sclerosis: association with HL-A3.
Tissue Antigens. 1972;2(1):1-4. doi: 10.1111/j.1399-0039.1972.tb00111.x.
7
HL-A antigens and diseases. I. Multiple sclerosis.
Tissue Antigens. 1973;3(4):243-50. doi: 10.1111/j.1399-0039.1973.tb01002.x.
8
HL-A antigens and multiple sclerosis.
Tissue Antigens. 1972;2(5):405-8. doi: 10.1111/j.1399-0039.1972.tb00060.x.
10
A rapid method for the isolation of functional thymus-derived murine lymphocytes.
Eur J Immunol. 1973 Oct;3(10):645-9. doi: 10.1002/eji.1830031011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验